Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Fa ...

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for allegedly making false and misleading statements regarding its financial guidance and business operations during the Class Period from February 26, 2025, to August 4, 2025 [3][7]. Allegation Details - The lawsuit claims that defendants issued guidance for 2025 that they knew or should have known was unattainable due to significant industry challenges [3]. - It is alleged that defendants overstated the immediate positive financial impact from strategic actions taken to mitigate risks [3]. - As a result, statements made about Agilon's business, operations, and prospects were materially false and misleading throughout the Class Period [3]. Next Steps - Investors who purchased Agilon shares and suffered losses are encouraged to contact the law firm for more information regarding their rights and potential claims [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is March 2, 2026 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation, including securities and commercial cases [5]. - The firm operates nationwide and handles cases in both federal and state courts [5].

SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is I ...

NEW YORK--(BUSINESS WIRE)---- $AGL #AGL--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. ("agilon†or the "Company†) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has. ...

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for alleged violations of securities laws, specifically related to misleading statements made by the company regarding its financial guidance and strategic actions [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Agilon's securities between February 26, 2025, and August 4, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against Agilon - The complaint alleges that Agilon made false and misleading statements to the market, particularly regarding its 2026 guidance, which was deemed unrealistic [4]. - The company is accused of overstating the effectiveness of its strategic actions aimed at reducing risk, leading to materially misleading public statements throughout the class period [4]. - As a result of the revelations about Agilon's true situation, investors reportedly suffered financial damages [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities for the period between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew or should have known was unattainable due to industry challenges [5]. - It is alleged that the defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action, which allows them to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].

Core Viewpoint - A securities fraud lawsuit has been filed against agilon health, inc. following a significant drop in its stock price due to the resignation of its CEO and the withdrawal of its financial guidance for 2025 [1][2]. Group 1: Company Developments - Shares of agilon health, Inc. fell more than 25% in after-hours trading on August 4, 2025, after the announcement of CEO Steven Sell's immediate resignation and the withdrawal of the full-year 2025 financial guidance [2]. - The company cited unexpected medical cost pressures and downward adjustments to prior revenue estimates as reasons for these actions [2]. Group 2: Allegations in the Lawsuit - The complaint alleges that agilon recklessly issued guidance for 2025 that they knew or should have known was unattainable due to material industry headwinds [3]. - It is claimed that agilon materially overstated the immediate positive financial impact from strategic actions taken to reduce risk, leading to materially false and/or misleading statements about the company's business and prospects [3]. Group 3: Investor Information - Investors who purchased agilon health, inc. common stock between February 26, 2025, and August 4, 2025, and have experienced a loss may be eligible to participate in the lawsuit [4]. - The deadline to seek appointment as lead plaintiff is March 2, 2026, and a class has not yet been certified [5]. Group 4: Whistleblower Information - Individuals with non-public information about agilon health, inc. are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [6]. Group 5: Legal Representation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired agilon securities between February 26, 2025 and August 4, 2025, both dates ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew was unattainable due to industry challenges [5]. - It is alleged that the defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the agilon class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by March 2, 2026, to represent other class members in the litigation [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities for the period between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew or should have known was unattainable due to industry challenges [5]. - It is alleged that defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Participation Information - Interested parties can join the agilon class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by March 2, 2026, to represent other class members in the litigation [1][3]. - No class has been certified yet, and investors can choose to remain absent or select their own counsel [7]. Group 3: Rosen Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].